Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?
Soleno Therapeutics Ownership Summary
Soleno Therapeutics is owned by 112.52% institutional investors, 3.05% insiders. Vivo capital is the largest institutional shareholder, holding 20.21% of SLNO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.12% of its assets in Soleno Therapeutics shares.
SLNO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Soleno Therapeutics | 112.52% | 3.05% | -15.56% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vivo capital | 7.32M | 20.21% | $298.53M |
Carlyle group | 4.07M | 11.24% | $166.36M |
Janus henderson group | 3.36M | 9.28% | $137.14M |
Perceptive advisors | 3.20M | 8.85% | $130.76M |
Nantahala capital management | 3.08M | 8.51% | $125.75M |
Adage capital partners gp | 2.85M | 7.88% | $116.45M |
Avoro capital advisors | 2.09M | 5.78% | $85.34M |
Blackrock | 1.86M | 5.15% | $76.03M |
Vanguard group | 1.50M | 4.15% | $61.31M |
Commodore capital lp | 1.43M | 3.94% | $58.14M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Vivo capital | 7.32M | 27.58% | $298.53M |
Carlyle group | 4.07M | 15.80% | $166.36M |
Nantahala capital management | 3.08M | 7.35% | $125.75M |
Commodore capital lp | 1.43M | 3.97% | $58.14M |
Ghost tree capital | 300.00K | 3.83% | $12.24M |
Vestal point capital, lp | 1.20M | 3.65% | $48.96M |
Altium capital management lp | 212.91K | 3.54% | $8.69M |
Perceptive advisors | 3.20M | 3.11% | $130.76M |
Frazier life sciences management | 875.67K | 1.67% | $35.73M |
Sofinnova investments | 554.36K | 1.18% | $22.62M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 1.86M | 0.00% | 1.54M |
Commodore capital lp | 1.43M | 3.97% | 1.26M |
Adage capital partners gp | 2.85M | 0.22% | 910.57K |
Nantahala capital management | 3.08M | 7.35% | 671.73K |
Holocene advisors, lp | 536.45K | 0.09% | 536.45K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vivo capital | 7.32M | 27.58% | -1.10M |
Assenagon asset management | - | - | -729.84K |
Invesco | 11.03K | 0.00% | -309.00K |
Ally bridge group (ny) | - | - | -286.16K |
Balyasny asset management | - | - | -247.21K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Holocene advisors, lp | 536.45K | 0.09% | 536.45K | $21.89M |
Polar asset management partners | 74.50K | 0.06% | 74.50K | $3.04M |
Nuveen asset management | 59.48K | 0.00% | 59.48K | $2.43M |
Norges bank | 57.77K | 0.00% | 57.77K | $2.36M |
Adar1 capital management | 39.93K | 0.31% | 39.93K | $1.63M |
Sold Out
Holder | Change |
---|---|
Harbour investments | -5.00 |
Entrypoint capital | -135.00 |
Visionpoint advisory group | -168.00 |
Pacer advisors | -307.00 |
Aquatic capital management | -900.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 156 | 31.09% | 47,121,280 | 8.78% | 112 | 0.79% | 103 | 30.38% | 24 | -4.00% |
Jun 30, 2024 | 119 | 10.19% | 43,316,980 | 21.90% | 119 | 1.24% | 79 | 3.95% | 25 | 66.67% |
Mar 31, 2024 | 108 | 28.57% | 35,536,015 | 13.14% | 98 | 1.18% | 76 | 35.71% | 15 | 15.38% |
Dec 31, 2023 | 84 | 55.56% | 31,409,972 | 54.72% | 91 | 2.62% | 56 | 33.33% | 13 | 62.50% |
Sep 30, 2023 | 54 | 145.45% | 20,301,195 | 318.35% | 59 | 29.65% | 42 | 600.00% | 8 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 915.09K | 2.12% | 1.50K |
Janus Henderson Global Life Sciences D | 627.57K | 1.61% | 38.81K |
SPDR® S&P Biotech ETF | 624.52K | 1.61% | 6.90K |
Janus Henderson Global Life Sciences | 639.63K | 1.48% | 60.45K |
iShares Russell 2000 ETF | 596.83K | 1.38% | -1.34K |
Janus Henderson Glb Life Scn I2 USD | 476.16K | 1.23% | 21.86K |
Janus Henderson US SMID Cap Growth | 466.95K | 1.20% | - |
Janus Henderson Triton D | 466.95K | 1.20% | - |
Janus Global Life Science AUSD | 476.16K | 1.10% | 57.56K |
T. Rowe Price All-Cap Opportunities Fund | 335.72K | 0.86% | 28.10K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 01, 2024 | Yen Kristen | SEE REMARKS | Sell | $16.03K |
Oct 01, 2024 | Yen Kristen | SEE REMARKS | Sell | $137.60K |
Oct 01, 2024 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | $357.59K |
Oct 01, 2024 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | $41.66K |
Oct 01, 2024 | Hirano Patricia C | SEE REMARKS | Sell | $137.60K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 8 |
2024 Q3 | - | 47 |
2024 Q2 | - | 10 |
2024 Q1 | - | 3 |
2023 Q4 | - | 31 |
SLNO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools